眼科市場：疾患別、製品タイプ別、エンドユーザー別-2025-2030年の世界予測

眼科市場の2023年の市場規模は597億8,000万米ドルで、2024年にはCAGR 6.62%で637億2,000万米ドルに成長し、2030年には936億9,000万米ドルに達すると予測されています。

近年、眼科分野は急速な技術進歩、進化する患者ニーズ、絶え間ない技術革新に後押しされ、ダイナミックな成長を遂げています。眼科業界の変革は、眼に関連する様々な疾患に対処しながら、患者の転帰を向上させるというコミットメントによって特徴付けられます。この進化する情勢は、厳密な調査、技術への多額の投資、臨床実践を改善する反復プロセスを反映しています。伝統的な手法が新しい診断ツールや治療プロトコルと交わるにつれて、この分野ではデジタルヘルスソリューションの統合が進み、効率性の向上と患者エンゲージメントの改善に繋がっています。

画期的な手術機器やデジタル画像技術の導入は、診断の精度を高めるだけでなく、治療介入の効果を増幅させるパラダイムシフトをもたらしました。こうした進歩は、継続的な調査と新たな市場ニーズの深い理解によって支えられています。ヘルスケア専門家、研究者、テクノロジー企業が協力し合うことで、ピアツーピアの学習とイノベーションのための肥沃な環境が実現し、患者ケアの新たな標準が設定されています。このエグゼクティブサマリーは、眼科医療の将来的な軌道を推進する上で最も重要な変革的力とセグメンテーション・ダイナミクスを解き明かす詳細な分析の舞台を整えるものです。

眼科の情勢を再定義する変革的変化

眼科市場は、臨床戦略と商業戦略の両方を再定義するような大きな変化を遂げつつあります。このような変化の最前線にあるのは、患者が治療を受ける方法を方向転換させた高度な診断・治療技術の統合です。業界の利害関係者は、デジタル・ソリューションと従来の治療方法の融合が、診断や外科手術の精度と効率を向上させることを目の当たりにしています。こうした変革的なシフトは、技術革新にとどまらず、個別化医療の導入を促す規制の枠組みや償還状況の進化にも及んでいます。

遠隔診断と患者モニタリングのための実行可能でスケーラブルなソリューションとしての遠隔医療の出現は、患者中心のケアへのより広範なシフトを反映しています。臨床医がデータ分析と人工知能を採用するにつれ、この分野では臨床的意思決定が改善され、ひいては治療成功率の向上が促進されます。同様に、拡張現実とロボット支援手術は、回復時間を短縮し合併症を最小限に抑えることで、精密医療における新たな道筋を開拓しています。

さらに、統合されたヘルスケアシステムを求める世界の声は、さまざまな研究機関、ヘルスケアプロバイダー、テクノロジー企業間の協力的な取り組みを促進しています。伝統的な治療パラダイムが革新的な方法によってますます課題されるようになるにつれ、眼科疾患全般を管理するための、よりアクセスしやすく、効率的かつ効果的なアプローチによって、眼科業界は恩恵を受けることになるでしょう。

市場力学を牽引するセグメンテーション洞察の深掘り

眼科市場の複雑さは、その多面的なセグメンテーションを通じて最もよく理解されます。疾患別に見ると、加齢黄斑変性、白内障、緑内障、炎症性疾患、屈折障害など、さまざまな疾患が含まれます。各疾患は、オーダーメイドの治療計画を必要とするだけでなく、標的治療アプローチの進歩の指標ともなります。

製品タイプ別に見ると、市場は医薬品、機器、処方眼鏡・レンズ、ソフトウェア・ソリューションに広がっています。医薬品の領域では、医薬品はさらにアレルギー性結膜炎・炎症治療薬、ドライアイ治療薬、緑内障治療薬、網膜障害治療薬などのセグメントに分類されます。機器もまた、診断機器と手術機器に二分される重要なカテゴリーです。手術機器そのものは、眼内レンズや眼科用レーザーを含むサブセグメントを構成しており、これらは現代の外科的介入において極めて重要です。この微妙な市場内訳により、業界各社は技術的・臨床的アプローチを継続的に改良しながら、特定の市場ニーズに対応することができます。

エンドユーザーに基づいて市場を評価すると、さらなる戦略的洞察が明らかになります。病院、医療機関、研究機関とともにヘルスケアを提供するサービスプロバイダーは、それぞれ眼科医療の提供において重要な役割を果たしています。このセグメンテーションは、患者のニーズ、医療インフラ、革新的治療が複雑に絡み合っていることを強調し、それによって、この分野における的を絞った投資と研究主導型の進歩のための明確な道筋を示すものです。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 眼疾患の有病率と国民の意識の高まり
    • 処方眼鏡やレンズの採用増加
    • 設備の整ったヘルスケアインフラの存在と医薬品承認数の増加
  • 抑制要因
    • 眼科治療の高額な費用
  • 機会
    • 眼科治療に関する新たな調査活動と助成金の利用可能性
    • 眼科の技術統合により、高い利用可能性が期待できます
  • 課題
    • 眼科手術の熟練した専門家が限られている
• 市場セグメンテーション分析
  • 疾患：人口のかなりの部分における近視、遠視、乱視、老眼などの屈折異常の有病率
  • 製品タイプ：眼科におけるソフトウェア開発への投資増加
  • エンドユーザー：世界中の医療機関による継続的な調査活動
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 眼科市場病気別

• 加齢黄斑変性症
• 白内障
• 緑内障
• 炎症性疾患
• 屈折異常

第7章 眼科市場：製品タイプ別

• 薬物
  • アレルギー性結膜炎および炎症薬
  • ドライアイ薬
  • 緑内障薬
  • 網膜疾患治療薬
• 装置
  • 診断装置
  • 外科用機器
    • 眼内レンズ
    • 眼科用レーザー
• 処方箋メガネとレンズ
• ソフトウェア

第8章 眼科市場：エンドユーザー別

• ヘルスケアサービスプロバイダー
• 病院
• 医療機関
• 調査機関

第9章 南北アメリカの眼科市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の眼科市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの眼科市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Alcon Inc.
• Alkeus Pharmaceuticals, Inc.
• Apotex Inc.
• Bausch Health Companies Inc.
• C.H. Boehringer Sohn AG & Co. KG
• Carl Zeiss AG
• ClearSight LLC
• Duopharma Biotech Berhad
• Essex Bio-Technology Limited
• EssilorLuxottica S.A.
• Eyenovia, Inc.
• F. Hoffmann-La Roche AG
• GenSight Biologics S.A.
• Geri-Care Pharmaceuticals Corp.
• Glaukos Corporation
• Halma PLC
• Harrow Health, Inc.
• Honeywell International Inc.
• Hoya Corporation
• Johnson & Johnson Services Inc.
• Kubota Pharmaceutical Holdings Co., Ltd.
• Lumenis Be Ltd. by Boston Scientific
• Nidek Co., Ltd.
• Novartis AG
• OCuSOFT, Inc.
• Oxurion NV
• Pfizer, Inc.
• Reichert by Ametek Inc.
• Santen Pharmaceutical Co., Ltd.
• SEED Co., Ltd.
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.
• The Cooper Companies, Inc.
• Topcon Corporation
• Unimed Pharma, Spols r.o.
• Visioncare Optolab Pvt. Ltd.
• Ziemer Group

LIST OF FIGURES

• FIGURE 1. OPHTHALMOLOGY MARKET MULTI-CURRENCY
• FIGURE 2. OPHTHALMOLOGY MARKET MULTI-LANGUAGE
• FIGURE 3. OPHTHALMOLOGY MARKET RESEARCH PROCESS
• FIGURE 4. OPHTHALMOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OPHTHALMOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OPHTHALMOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 54. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 57. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 58. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 86. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 88. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 89. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 90. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 92. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 94. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 95. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 96. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. ITALY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 195. ITALY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 196. ITALY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 197. ITALY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 198. ITALY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. ITALY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. POLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 219. POLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 220. POLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 221. POLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 222. POLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. POLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. QATAR OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 225. QATAR OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 226. QATAR OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 227. QATAR OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 228. QATAR OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. QATAR OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 285. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The Ophthalmology Market was valued at USD 59.78 billion in 2023 and is projected to grow to USD 63.72 billion in 2024, with a CAGR of 6.62%, reaching USD 93.69 billion by 2030.

In recent years the ophthalmology sector has experienced dynamic growth fueled by rapid technological advancements, evolving patient needs, and continuous innovation. The industry's transformation is marked by a commitment to enhancing patient outcomes while addressing a diverse range of eye-related conditions. This evolving landscape reflects rigorous research, substantial investments in technology, and an iterative process of improving clinical practices. As traditional methodologies intersect with novel diagnostic tools and treatment protocols, the sector also sees broader integration of digital health solutions, leading to increased efficiency and improved patient engagement.

The introduction of breakthrough surgical equipment and digital imaging techniques has brought about a paradigm shift that not only increases the accuracy of diagnostics but also amplifies the effectiveness of therapeutic interventions. Such advancements are supported by ongoing research and a deep understanding of emerging market needs. The collaboration among healthcare professionals, researchers, and technology firms has enabled a fertile environment for peer-to-peer learning and innovation, setting new standards in patient care. This executive summary sets the stage for an in-depth analysis that unpacks the transformative forces and segmentation dynamics which are paramount in driving the future trajectory of ophthalmology.

Transformative Shifts Redefining the Ophthalmology Landscape

The ophthalmology market is undergoing significant shifts that are redefining both clinical and commercial strategies. At the forefront of these changes is the integration of advanced diagnostic and therapeutic technologies that have reoriented how patients receive care. Industry stakeholders are witnessing a convergence between digital solutions and traditional treatment modalities, resulting in improved accuracy and efficiency in diagnosis as well as in surgical procedures. These transformative shifts extend beyond technological innovation; they touch upon evolving regulatory frameworks and reimbursement landscapes that encourage the adoption of personalized care.

The emergence of telemedicine as a viable and scalable solution for remote diagnosis and patient monitoring reflects a broader shift towards patient-centric care. As clinicians embrace data analytics and artificial intelligence, the field sees improved clinical decision-making which in turn promotes higher treatment success rates. Similarly, augmented reality and robotic-assisted surgeries are pioneering new pathways in precision medicine by reducing recovery times and minimizing complications.

Furthermore, the global call for integrated healthcare systems is driving collaborative efforts across various research institutes, healthcare providers, and technology companies. As traditional treatment paradigms are increasingly challenged by innovative methods, the industry is set to benefit from a more accessible, efficient, and effective approach to managing a wide range of ophthalmic conditions.

Deep Dive into Segmentation Insights Driving Market Dynamics

The complexity of the ophthalmology market is best understood through its multifaceted segmentation, which offers a clear picture of the diverse factors influencing its growth. When examined by disease, the market encompasses a range of conditions including Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders. Each condition not only demands tailor-made treatment plans but also serves as a benchmark for advancements in targeted therapeutic approaches.

Looking at the product type, the market expands into drugs, equipment, prescription glasses and lenses, and software solutions. Within the realm of pharmaceuticals, drugs are further categorized into segments such as Allergic Conjunctivitis and Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. Equipment is another critical category that bifurcates into diagnostic devices and surgical devices. Surgical devices themselves constitute a sub-segment including intraocular lenses and ophthalmic lasers which are pivotal in modern surgical interventions. This nuanced breakdown enables industry players to address specific market needs while continually refining their technological and clinical approaches.

Evaluating the market based on end user reveals further strategic insights. Service providers that deliver healthcare along with hospitals, medical institutes, and research organizations each play a vital role in the delivery of eye care. This segmentation underscores the intricate interplay between patient needs, medical infrastructure, and innovative treatments, thereby setting a clear path for targeted investments and research-driven advancements in the field.

Based on Diseases, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.

Based on Product Type, market is studied across Drugs, Equipment, Prescription Glasses & Lens, and Software. The Drugs is further studied across Allergic Conjunctivitis & Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. The Equipment is further studied across Diagnostic Devices and Surgical Devices. The Surgical Devices is further studied across Intraocular Lenses and Ophthalmic Lasers.

Based on End User, market is studied across Healthcare Service Providers, Hospitals, Medical Institutes, and Research Organizations.

Regional Insights Shaping Global Ophthalmology Trends

Regional analysis provides crucial visibility into the broad spectrum of growth opportunities and healthcare challenges that shape the ophthalmology market globally. In the Americas, advanced healthcare infrastructure combined with a high level of technological adoption has fostered a robust environment for clinical research and market expansion. Market dynamics in this region are heavily characterized by a strong emphasis on patient-centric innovations and the rapid adoption of digital diagnostic tools.

Across Europe, the Middle East, and Africa, there exists a diverse mix of market maturity levels. Innovative healthcare policies, combined with significant investments in research and development, propel performance improvements and enhanced patient care. Regulatory frameworks in these regions are designed to support both emerging and established players, thereby nurturing an environment of healthy competition and breakthrough innovations.

In the Asia-Pacific region, the growing economies and increasing healthcare awareness have resulted in a surge in demand for sophisticated healthcare services and state of the art diagnostic equipment. Rapid urbanization, coupled with an expanding population, drives the need for scalable and efficient ophthalmic solutions. The interplay of these factors not only broadens market participation but also fuels the development of cost-effective treatment modalities that can be seamlessly integrated into both rural and metropolitan healthcare systems.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights Driving Competitive Advantage

Competitive leadership in the ophthalmology market is predominantly steered by companies that have consistently demonstrated innovation and strategic foresight. Leading industry players include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch Health Companies Inc., C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight LLC, Duopharma Biotech Berhad, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd. by Boston Scientific, Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., Reichert by Ametek Inc., Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., The Cooper Companies, Inc., Topcon Corporation, Unimed Pharma, Spols r.o., Visioncare Optolab Pvt. Ltd., and Ziemer Group.

These organizations have carved out distinct market positions by investing heavily in research and development and forging strategic alliances that extend their operational capacities both in the domestic and international arenas. Their innovative product portfolios, supported by continuous advancements in technology and impeccable clinical performance records, contribute to heightened industry standards. The synergy between research excellence and commercial strategy has resulted in improved treatment outcomes and a reinforced commitment to patient-centric approaches, thereby driving sustainable market growth.

The report delves into recent significant developments in the Ophthalmology Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch Health Companies Inc., C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight LLC, Duopharma Biotech Berhad, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd. by Boston Scientific, Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., Reichert by Ametek Inc., Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., The Cooper Companies, Inc., Topcon Corporation, Unimed Pharma, Spols r.o., Visioncare Optolab Pvt. Ltd., and Ziemer Group. Strategic Recommendations for Industry Leaders

Industry leaders are advised to harness current market trends by focusing on investments in research and development while fostering collaborations that bridge clinical expertise with technological innovation. Embracing digital transformation is essential for improving diagnostic precision and enhancing treatment protocols. A shift towards integrating data analytics and artificial intelligence into clinical decision-making processes can convert raw clinical data into actionable insights, ultimately refining patient care.

Moreover, it is crucial for organizations to actively pursue strategic partnerships with both emerging technology firms and established research institutions. Such collaborative ventures facilitate the exchange of knowledge and promote creations of multi-faceted solutions that address complex ophthalmic conditions. Market leaders should also consider diversifying their product portfolios to include a broader range of drugs and equipment that cater to both high-end and cost-effective treatment options.

Taking proactive steps to monitor evolving regulatory landscapes and patient demographics can further enable leaders to adapt quickly to market changes. Emphasizing sustainable practices while ensuring clinical excellence will not only enhance brand reputation but also ensure long-term viability in an increasingly competitive landscape. By aligning innovation with operational efficiency, industry players stand well-positioned to capitalize on the emerging trends in the ophthalmology market.

Conclusion: Charting the Future for Ophthalmology

The evolving landscape of ophthalmology exemplifies a delicate balance between technological innovation, strategic partnerships, and patient-focused initiatives. Through a detailed examination of market segmentation, regional dynamics, and competitive forces, the findings highlight a clear trajectory pointing towards enhanced diagnostic precision, integrated treatment modalities, and robust patient care. Industry advances in digital health, coupled with sustained investments in research and development, are driving the transformation of care across diverse regions and patient segments.

The convergence of innovative products and clinical excellence is setting new benchmarks in the industry. By capitalizing on technological breakthroughs and tailoring solutions to specific patient needs, stakeholders remain at the forefront of driving change. To realize the full potential of these transformative trends, a collaborative approach that unites clinical expertise with commercial acumen is imperative. This summary encapsulates the fundamental factors propelling the sector forward and reinforces the commitment to achieving higher standards of patient care and business growth.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of eye disorders and growing awareness among the population
    • 5.1.1.2. Increasing adoption of prescription glasses and lenses
    • 5.1.1.3. Presence of well-equipped healthcare infrastructure and an increasing number of drug approvals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of ophthalmologic treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging research activities of ophthalmology treatments and availability of grants
    • 5.1.3.2. High usage potential owing to the technological integrations in Ophthalmology
  • 5.1.4. Challenges
    • 5.1.4.1. Limited skilled professionals for ophthalmic procedures
• 5.2. Market Segmentation Analysis
  • 5.2.1. Diseases: Prevalence of refractive errors such as myopia, hyperopia, astigmatism, and presbyopia in a significant portion of the population
  • 5.2.2. Product Type: Increasing investments in software development in ophthalmology
  • 5.2.3. End User: Continuous research activities by medical institutes worldwide
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Ophthalmology Market, by Diseases

• 6.1. Introduction
• 6.2. Age-Related Macular Degeneration
• 6.3. Cataract
• 6.4. Glaucoma
• 6.5. Inflammatory Diseases
• 6.6. Refractive Disorders

7. Ophthalmology Market, by Product Type

• 7.1. Introduction
• 7.2. Drugs
  • 7.2.1. Allergic Conjunctivitis & Inflammation Drugs
  • 7.2.2. Dry Eye Drugs
  • 7.2.3. Glaucoma Drugs
  • 7.2.4. Retinal Disorder Drugs
• 7.3. Equipment
  • 7.3.1. Diagnostic Devices
  • 7.3.2. Surgical Devices
    • 7.3.2.1. Intraocular Lenses
    • 7.3.2.2. Ophthalmic Lasers
• 7.4. Prescription Glasses & Lens
• 7.5. Software

8. Ophthalmology Market, by End User

• 8.1. Introduction
• 8.2. Healthcare Service Providers
• 8.3. Hospitals
• 8.4. Medical Institutes
• 8.5. Research Organizations

9. Americas Ophthalmology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Ophthalmology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Eyenovia and Formosa Pharmaceuticals collaborate to co-develop clobetasol suspension for dry eye disease relief leveraging Optejet technology
  • 12.3.2. Beacon Therapeutics secures USD 170 Million in series B funding to propel ophthalmic gene therapies and drive global expansion
  • 12.3.3. Thea Pharma Inc. introduced new resources to support latanoprost ophthalmic solution patients
  • 12.3.4. BioPhta raises EUR 6.5 million to propel innovative eye disease treatments to clinical trials and expand global reach
  • 12.3.5. Merck's strategic acquisition of EyeBio aims to advance groundbreaking therapies for retinal diseases
  • 12.3.6. Clario and EmSere forge strategic partnership to revolutionize ophthalmic clinical trials with advanced imaging and data integration
  • 12.3.7. Biocon Biologics Limited received U.S. FDA approval for biosimilar aflibercept, enters U.S. ophthalmology market
  • 12.3.8. Topcon and Microsoft join forces to revolutionize ophthalmic diagnostics with AI-powered healthcare platform
  • 12.3.9. A collaboration between Eye2Gene Limited and Heidelberg Engineering, Inc. was announced at ARVO 2024
  • 12.3.10. Nordic Pharma, Inc. gears up for LACRIFILL launch at ASCRS annual meeting
  • 12.3.11. Carl Zeiss Meditec AG strengthens ophthalmology market position with strategic D.O.R.C. acquisition
  • 12.3.12. Viatris leads innovation with the launch of RYZUMVI(TM) 0.75% to revolutionize eye dilation management
  • 12.3.13. Clario and Cleveland Clinic Foundation's Cole Eye Institute formed a strategic partnership for enhanced ophthalmology clinical trials
  • 12.3.14. Roche's Vabysmo launch in India aims to revolutionize retinal disease treatment with affordability and accessibility
  • 12.3.15. Refocus Eye Health is partnering with eight premier practices in New Jersey to enhance specialized eye services
  • 12.3.16. Ikerian AG unveiled a discovery core platform for enhanced ophthalmic data analysis
  • 12.3.17. Cipla joins forces with CSIR-CDRI to innovate ophthalmic antifungal treatments, accelerating R&D and global market reach
• 12.4. Strategy Analysis & Recommendation
  • 12.4.1. Alcon Inc.
  • 12.4.2. EssilorLuxottica S.A.
  • 12.4.3. AbbVie Inc.
  • 12.4.4. Bausch Health Companies Inc.

Companies Mentioned

• 1. AbbVie Inc.
• 2. Alcon Inc.
• 3. Alkeus Pharmaceuticals, Inc.
• 4. Apotex Inc.
• 5. Bausch Health Companies Inc.
• 6. C.H. Boehringer Sohn AG & Co. KG
• 7. Carl Zeiss AG
• 8. ClearSight LLC
• 9. Duopharma Biotech Berhad
• 10. Essex Bio-Technology Limited
• 11. EssilorLuxottica S.A.
• 12. Eyenovia, Inc.
• 13. F. Hoffmann-La Roche AG
• 14. GenSight Biologics S.A.
• 15. Geri-Care Pharmaceuticals Corp.
• 16. Glaukos Corporation
• 17. Halma PLC
• 18. Harrow Health, Inc.
• 19. Honeywell International Inc.
• 20. Hoya Corporation
• 21. Johnson & Johnson Services Inc.
• 22. Kubota Pharmaceutical Holdings Co., Ltd.
• 23. Lumenis Be Ltd. by Boston Scientific
• 24. Nidek Co., Ltd.
• 25. Novartis AG
• 26. OCuSOFT, Inc.
• 27. Oxurion NV
• 28. Pfizer, Inc.
• 29. Reichert by Ametek Inc.
• 30. Santen Pharmaceutical Co., Ltd.
• 31. SEED Co., Ltd.
• 32. Sun Pharmaceutical Industries Limited
• 33. Teva Pharmaceutical Industries Ltd.
• 34. The Cooper Companies, Inc.
• 35. Topcon Corporation
• 36. Unimed Pharma, Spols r.o.
• 37. Visioncare Optolab Pvt. Ltd.
• 38. Ziemer Group